CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Beginning balance at Dec. 31, 2021	$ 3	$ 346,312	$ (160,886)	$ 185,429
Beginning balance (in shares) at Dec. 31, 2021	27,358,375
Stockholders' Deficit
Vesting of restricted common stock (in shares)	15,441
Exercise of stock options		16		16
Exercise of stock options (in shares)	2,657
Stock-based compensation expense		2,029		2,029
Net loss			(21,353)	(21,353)
Ending balance at Mar. 31, 2022	$ 3	348,357	(182,239)	166,121
Ending balance (in shares) at Mar. 31, 2022	27,376,473
Beginning balance at Dec. 31, 2021	$ 3	346,312	(160,886)	185,429
Beginning balance (in shares) at Dec. 31, 2021	27,358,375
Stockholders' Deficit
Net loss				(65,756)
Ending balance at Sep. 30, 2022	$ 3	352,937	(226,642)	126,298
Ending balance (in shares) at Sep. 30, 2022	27,407,149
Beginning balance at Mar. 31, 2022	$ 3	348,357	(182,239)	166,121
Beginning balance (in shares) at Mar. 31, 2022	27,376,473
Stockholders' Deficit
Vesting of restricted common stock (in shares)	15,361
Stock-based compensation expense		2,709		2,709
Net loss			(24,613)	(24,613)
Ending balance at Jun. 30, 2022	$ 3	351,066	(206,852)	144,217
Ending balance (in shares) at Jun. 30, 2022	27,391,834
Stockholders' Deficit
Vesting of restricted common stock (in shares)	15,315
Stock-based compensation expense		1,871		1,871
Net loss			(19,790)	(19,790)
Ending balance at Sep. 30, 2022	$ 3	352,937	(226,642)	126,298
Ending balance (in shares) at Sep. 30, 2022	27,407,149
Beginning balance at Dec. 31, 2022	$ 3	354,752	(249,108)	105,647
Beginning balance (in shares) at Dec. 31, 2022	27,425,447
Stockholders' Deficit
Vesting of restricted common stock (in shares)	14,217
Exercise of stock options (in shares)	156
Stock-based compensation expense		1,791		1,791
Net loss			(22,646)	(22,646)
Ending balance at Mar. 31, 2023	$ 3	356,543	(271,754)	84,792
Ending balance (in shares) at Mar. 31, 2023	27,439,820
Beginning balance at Dec. 31, 2022	$ 3	354,752	(249,108)	$ 105,647
Beginning balance (in shares) at Dec. 31, 2022	27,425,447
Stockholders' Deficit
Exercise of stock options (in shares)				2,757
Net loss				$ (58,749)
Ending balance at Sep. 30, 2023	$ 3	360,352	(307,857)	52,498
Ending balance (in shares) at Sep. 30, 2023	27,528,926
Beginning balance at Mar. 31, 2023	$ 3	356,543	(271,754)	84,792
Beginning balance (in shares) at Mar. 31, 2023	27,439,820
Stockholders' Deficit
Issuance of common stock under employee stock purchase plan		140		140
Issuance of common stock under employee stock purchase plan (in shares)	68,929
Vesting of restricted common stock (in shares)	9,978
Exercise of stock options (in shares)	168
Stock-based compensation expense		1,800		1,800
Net loss			(19,355)	(19,355)
Ending balance at Jun. 30, 2023	$ 3	358,483	(291,109)	67,377
Ending balance (in shares) at Jun. 30, 2023	27,518,895
Stockholders' Deficit
Vesting of restricted common stock (in shares)	7,598
Exercise of stock options		8		8
Exercise of stock options (in shares)	2,433
Stock-based compensation expense		1,861		1,861
Net loss			(16,748)	(16,748)
Ending balance at Sep. 30, 2023	$ 3	$ 360,352	$ (307,857)	$ 52,498
Ending balance (in shares) at Sep. 30, 2023	27,528,926